28-7 Therapeutics raises $65M for cancer drugs aimed at tumor-suppressing RNA

28-7 Therapeutics raises $65M for cancer drugs aimed at tumor-suppressing RNA

Source: 
Fierce Biotech
snippet: 

Twentyeight-Seven Therapeutics has launched with $65 million in venture capital to fund its treatments for a variety of cancers, which aim to modulate noncoding strands of microRNA to increase the levels of tumor-suppressing genes.